The Karu Abattoir in the Federal Capital Territory (FCT) of Nigeria is the ground zero for an alarming healthcare crisis. Veterinarian and researcher, Dr. Matthew Chibuzor, is at the frontlines – tracking the spread of drug-resistant bacteria from animals to humans. His disturbing discovery reveals the presence of multidrug-resistant Salmonella and E. coli strains not only in the meat but also among the workers handling the animals.
These bacteria are not confined to the abattoir. They infiltrate households and hospitals, resulting in life-threatening bloodstream infections resistant to conventional antibiotics. As pointed out by the World Health Organization (WHO), this issue of antimicrobial resistance (AMR) is a rising global challenge threatening the efficacy of treatments for bacterial, viral, fungal and parasitic infections. As per 2019 data, AMR fueled 1.27 million deaths globally and without intervention, by 2050, it could claim 10 million lives annually.
Countries like Nigeria, grappling with healthcare infrastructure deficiencies, high disease burdens and limited surveillance, are the most vulnerable. Mary Goma’s frightening experience echoes this vulnerability. Her young son became seriously ill due to typhoid fever, but the antibiotics failed due to Salmonella typhai developing resistance. Her story is one among the countless threads stitching Nigeria’s public health disaster fabric.
Unhealthy practices like purchasing antibiotics over the counter without a prescription, substandard or falsified antibiotics, and prematurely discontinuing treatment are contributing to the rise of resistant bacteria. Poor hygiene in healthcare facilities facilitates bacteria spread, and routine antibiotics given to livestock fast-tracks resistance spread to humans through meat.
Data by the Nigeria Centre for Disease Control (NCDC) estimates upward of 20,000 deaths annually in Nigeria due to AMR-related infections. If the situation deteriorates, healthcare expenses and productivity loss could cost billions. Infectious disease specialist Dr. Samuel Olutuche highlights this economic crisis by citing the case of a newborn whose treatment required a last-resort, high-cost antibiotic. As projected by the World Bank, by 2050, Nigeria could see a 3.8% decline in GDP, pushing more families into poverty due to AMR.
Identifying this critical issue, the Management Sciences for Health (MSH) is supporting Nigeria through Phase 2 of The Fleming Fund’s country grant. This project aims to enhance AMR data quality and policy impact using a ‘One Health’ approach, targeting laboratory systems, data management, and workforce capacity across significant health sectors.
Despite the international support, Nigeria struggles with weak regulation and substandard antibiotics flooding the market, unaware populace unaware of the antibiotic misuse dangers, and gaps in hospital diagnostics.
While international funding is vital, grassroots initiatives educate the public about the hazards of self-prescribing antibiotics and promoting alternative livestock feed, which are integral for changing behaviours and managing resistance.
Prominent health advocates strongly recommend collaborations between governments, researchers, and the private sector. They press for stricter policies, better enforcement actions to avoid antibiotic overuse, improved hospital infection control for healthcare setting hygiene, and enhanced surveillance and research for monitoring resistance patterns and adjusting treatment protocols accordingly.
Without quick intervention, the cornerstone of modern medicine is at a significant risk, turning minor infections into deadly diseases. This fight against antimicrobial resistance is indeed a race against time.
Source: https://sciencenigeria.com/strengthening-nigerias-response-to-antimicrobial-resistance/